Intuitive Surgical Beats Q1 Estimates as da Vinci 5 Adoption Accelerates

Intuitive Surgical (ISRG) delivered a robust first-quarter performance for 2026, significantly exceeding Wall Street's expectations for both top- and bottom-line growth. The robotic surgery pioneer saw revenue climb 23% year-over-year to $2.77 billion, surpassing the consensus estimate of $2.62 billion. The growth was underpinned by a sharp increase in procedure volumes and the rapid adoption of the company's latest hardware. Non-GAAP earnings per share surged 38% to $2.50, beating the $2.11 forecast, reflecting strong operating leverage and expanded margins. The company placed 431 da Vinci systems during the quarter, a 17% increase from the previous year. Notably, the new da Vinci 5 platform accounted for 232 of these placements, representing more than half of the total. Worldwide procedure volume also grew by approximately 17%. Profitability metrics improved, with adjusted gross margins reaching 67.8% and operating margins hitting 39%. Consequently, management raised its 2026 guidance for procedure growth to a range of 13.5% to 15.5% and increased its gross profit margin outlook to 67.5% to 68.5%. Despite the momentum, the company noted pricing pressures and domestic competition in China, as well as caution regarding the Japanese public hospital sector. Investors are weighing these results against a high valuation, with the stock trading at approximately 51 times adjusted trailing 12-month earnings.